MannKind | Beban Penjualan Dan Administrasi



Selling And Administration Expenses Perubahan Tanggal
Adma Biologics USD 24.59M 5.01M 2024-12
Dynavax Technologies USD 41.54M 64.79M 2025-06
Eli Lilly USD 2.75B 390.8M 2025-06
Halozyme Therapeutics USD 33M 9.36M 2025-06
Insmed USD 76.44M 71.11M 2025-06
MacroGenics USD 27.81M 13.71M 2024-12
MannKind USD 31.62M 6.61M 2025-06
Merck USD 2.63B 104M 2025-06
Novo Nordisk DKK 16.11B 480M 2025-03
Pfizer USD 3.42B 406M 2025-06
Sanofi EUR 2.63B 408M 2025-06
Xencor USD 15.11M 2.22M 2025-06


MannKind Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Aug 2025.